Rise in sale of counterfeit obesity reducing drugs
Websites and stores selling counterfeit semaglutide products amidst the rise in demand. The World Health Organization (WHO) has issued a global alert concerning counterfeit diabetes drugs, specifically semaglutide GLP-1, which are being sold under brand names such as Ozempic and Wegovy, as well as unbranded products. These medications are intended for the treatment of type […]
Research funding in Canada’s federal budget
Top researchers in the field of type 1 diabetes (T1D) signed an open letter in support of renewed funding for the JDRF (now Breakthrough T1D) and CIHR (Canadian Institutes of Health Research) Partnership to Defeat diabetes through Federal Budget 2024, for a promising approach to curing type 1 diabetes (T1D) called islet replacement therapy. In […]
A Leap for Students in India
Students in India can now carry glucometers and strips, medicines, snacks and water India has the largest number of children with diabetes, but the country’s education system, like many others in the world, did not allow the students to carry their diabetes supplies and hypo snacks, and use them during exams. This caused great agony […]
Baby food found to contain more added sugars in low-and-middle income countries
A recent investigation conducted by Public Eye and the Baby Food Action Network has revealed alarming discrepancies in the sugar content of Nestlé baby foods sold across different regions. An international study, conducted in Belgium, sampled Nestlé’s baby food products, collected from Asia, Latin America, and Africa, that were analyzed for sugar content. The results […]
Make It Work
The World Health Organisation held an international summit in April 2021 at which a Global Compact, focussing on setting global coverage targets for diabetes care was launched. A key aim of the Global Diabetes Compact was to unite key stakeholders from the public and private sectors, and, critically, people who live with diabetes, around […]
Help Save Lives
As more and more establishments, public buildings and public places host defibrillators to assist in the event of a cardiac arrest, people with diabetes are campaigning for Glucogon to be more widely available to inject when someone with diabetes suffers a hypoglycaemic event. Glucagon is a hormone that your pancreas makes to help regulate your blood […]
French Move Could Help Others
In France, the Fédération Française des Diabetiques said it “welcomes the inclusion of Omnipod 5” on its list of reimbursable products and services. Omnipod 5, an insulin patch pump, delivers automated management for type 1 diabetes. France’s Haute Autorité de Santé — the country’s high health authority — issued an indication for the system to […]
Local insulin production in Pakistan
The country with the 5th largest population will have over 60 million people living with diabetes by 2045. Rising inflation rates in Pakistan have made it difficult for insulin manufacturers to import insulin and market them at the prices capped by the country’s drug regulatory authority. This has led to three critical shortages of insulin […]
Disparities in Access to Insulin Pumps in Scotland
There is a critical situation regarding access to insulin pump technology for people with diabetes in Scotland. According to reports, the health board in Lothian has limited pump availability to children and pregnant women only. People with diabetes who rely on pumps for managing their condition may face challenges if they are unable to access […]
Your Spotlight
What’s your story as an advocate – the barriers you face, the issues that matter, successes you’ve had – let others know. Battling Fake Diabetes Cures: Addressing Misinformation on Chronic Conditions in Africa, by: Lejla Driškić Mustafić Introduction Diabetes is a growing health concern across Africa, with the prevalence of the condition rising rapidly. According […]
The Power of Lived Experience in Diabetes Care
A comment in The Lancet journal (https://www.thelancet.com/journals/landia/article/PIIS2213-8587(24)00032-9/abstract) highlights the importance of community involvement in diabetes policymaking and provides key insights into how such policies can benefit people living with diabetes, health professionals, health service providers, and diabetes community organisations. Most national and international research funding bodies now require community involvement in diabetes care. To be […]
Emma Klatman – Leading the Charge in Advocacy!
“Diabetes didn’t happen to me ; it happened for me” Emma Klatman illuminated the conversation as she shared her compelling journey in diabetes advocacy during our recent interview. Serving as the Global Policy and Advocacy Manager at Life for a Child, an organization extending support to over 58,000 children and young individuals living with diabetes […]
From Sana’s Desk – An unforgettable Purple Heart story
Insurance Coverage – a determinant of health and life for young people with diabetes in the US! Some time ago, I watched a Netflix movie “The Purple Heart” with horror. Later, I convinced myself that the story may be unique or fictitious! If you have not watched it yet, I recommend you to do so. […]
Research News
T1D Screening Effect of population-wide screening for presymptomatic early-stage type 1 diabetes on paediatric clinical care. https://www.thelancet.com/journals/landia/article/PIIS2213-8587(24)00101-3/fulltext CGMs Use of continuous glucose monitoring (CGM) is now considered standard of care for people with T1D. New data continues to show the clinical benefits from CGM in people with type 2 diabetes, including those who don’t use […]
Why a Diabetes Advocacy Network?
Advocates work to ensure that individuals or groups receive fair treatment, access to resources, and opportunities to have their voices heard in various contexts, such as medical, employment, or political matters. Everyone can be an advocate and advocacy empowers individuals to articulate their needs, put right injustices, and bring about positive change. It allows for […]